104 related articles for article (PubMed ID: 19631836)
21. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
[TBL] [Abstract][Full Text] [Related]
22. Predicting and preventing stroke after transient ischemic attack.
de Lau LM; den Hertog HM; van den Herik EG; Koudstaal PJ
Expert Rev Neurother; 2009 Aug; 9(8):1159-70. PubMed ID: 19673605
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness and safety of carotid artery stenting for significant carotid stenosis in patients with contralateral occlusion (from the German ALKK-CAS Registry experience).
Mehta RH; Zahn R; Hochadel M; Mudra H; Ischinger T; Hauptmann KE; Jung J; Seggewiss H; Zeymer U; Senges J;
Am J Cardiol; 2009 Sep; 104(5):725-31. PubMed ID: 19699352
[TBL] [Abstract][Full Text] [Related]
24. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH;
Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051
[TBL] [Abstract][Full Text] [Related]
25. Drug treatment and cost of cardiovascular disease in Australia.
Ademi Z; Liew D; Chew D; Conner G; Shiel L; Nelson M; Soman A; Steg G; Bhatt DL; Reid C;
Cardiovasc Ther; 2009; 27(3):164-72. PubMed ID: 19689615
[TBL] [Abstract][Full Text] [Related]
26. Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene?
Coller BS
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):658-70. PubMed ID: 15662026
[TBL] [Abstract][Full Text] [Related]
27. Role of prasugrel, a novel P2Y(12) receptor antagonist, in the management of acute coronary syndromes.
Baker WL; White CM
Am J Cardiovasc Drugs; 2009; 9(4):213-29. PubMed ID: 19655817
[TBL] [Abstract][Full Text] [Related]
28. Sirolimus-eluting stent treatment at high-volume centers confers lower mortality at 6-month follow-up: results from the prospective multicenter German Cypher Registry.
Khattab AA; Hamm CW; Senges J; Toelg R; Geist V; Bonzel T; Kelm M; Levenson B; Nienaber CA; Pfannebecker T; Sabin G; Schneider S; Tebbe U; Neumann FJ; Richardt G;
Circulation; 2009 Aug; 120(7):600-6. PubMed ID: 19652087
[TBL] [Abstract][Full Text] [Related]
29. TP receptor antagonism: a new concept in atherothrombosis and stroke prevention.
Chamorro A
Cerebrovasc Dis; 2009; 27 Suppl 3():20-7. PubMed ID: 19439937
[TBL] [Abstract][Full Text] [Related]
30. An examination of economic outcomes associated with misdiagnosis or undertreatment of TIA.
Kessler C; Thomas KE
Am J Manag Care; 2009 Jun; 15(6 Suppl):S170-6. PubMed ID: 19601692
[TBL] [Abstract][Full Text] [Related]
31. Hypertension and TIA.
Zhang WW; Cadilhac DA; Donnan GA; O'Callaghan C; Dewey HM
Int J Stroke; 2009 Jun; 4(3):206-14. PubMed ID: 19659823
[TBL] [Abstract][Full Text] [Related]
32. Neurologists' evaluation and treatment of hyperhomocysteinemia in stroke patients.
Bushnell CD; Goldstein LB
J Stroke Cerebrovasc Dis; 2005; 14(3):101-6. PubMed ID: 17904008
[TBL] [Abstract][Full Text] [Related]
33. Learning lessons from REACH.
Kassianos GC
Int J Clin Pract; 2007 Nov; 61(11):1786-8. PubMed ID: 17935542
[No Abstract] [Full Text] [Related]
34. Gouty arthritis in acute cerebrovascular disease.
Lin YH; Hsu HL; Huang YC; Lee M; Huang WY; Huang YC; Lee TH; Lee JD
Cerebrovasc Dis; 2009; 28(4):391-6. PubMed ID: 19696479
[TBL] [Abstract][Full Text] [Related]
35. Prognostic impact of types of atrial fibrillation in acute coronary syndromes.
Lau DH; Huynh LT; Chew DP; Astley CM; Soman A; Sanders P
Am J Cardiol; 2009 Nov; 104(10):1317-23. PubMed ID: 19892044
[TBL] [Abstract][Full Text] [Related]
36. Possible mechanisms and controversies of protective effects of risk factors against stroke severity.
Bang OY
J Neurol Sci; 2008 Apr; 267(1-2):188-9. PubMed ID: 18054047
[No Abstract] [Full Text] [Related]
37. Polyvascular atherosclerotic disease: recognizing the risks and managing the syndrome.
Yakubov S
Curr Med Res Opin; 2009 Nov; 25(11):2631-41. PubMed ID: 19769467
[TBL] [Abstract][Full Text] [Related]
38. Workshop on secondary prevention of myocardial infarction and stroke and management of cardiovascular risk.
Mendis S
Anadolu Kardiyol Derg; 2003 Dec; 3(4):366-7. PubMed ID: 14675893
[No Abstract] [Full Text] [Related]
39. Potential survival gains in the treatment of myocardial infarction.
Chew DP; Huynh LT; Liew D; Astley C; Soman A; Brieger D
Heart; 2009 Nov; 95(22):1844-50. PubMed ID: 19666459
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular risk assessment and treatment in systemic lupus erythematosus.
Elliott JR; Manzi S
Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):481-94. PubMed ID: 19591779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
